The Influence of Cryopreservation on Activity and Surface Markers of Lymphokine‐Activated Killer Cells

Vox Sanguinis - Tập 61 Số 2 - Trang 90-95 - 1991
C. Letellier1, L. Rameliarison2, D. Fizet2, A.M. Ferrer2, G Vezon2
1Service d'immunologie cellulaire, CRTS de Bordeaux, France.
2Service d'immunologie cellulaire, CRTS de Bordeaux, Bordeaux, France

Tóm tắt

AbstractFicoll‐separated and monocyte‐depleted mononuclear cells isolated from normal leukapheresis products were cryopreserved. These cells were incubated with or without 1,000 U/ml of recombinant interleukin‐2 (rIL‐2) for 4 days, and their lymphokine‐activated killer (LAK) and natural killer (NK) activities were measured. IL‐2 activation induced a significant increase in the expression of the CD25 antigen. There was no change in CD2, CD3, CD4, CD8, CD16, CD56 and CD57 cell marker expression. Cryopreservation did not induce any change in the membrane antigen expression and in the lymphocyte subsets. The NK activity was well preserved and the decrease of LAK activity of IL‐2‐activated cells after cryopreservation was not significant. In contrast, cells activated before cryopreservation had a significantly lower cytotoxic activity and the number of cells expressing the IL‐2 receptor was also significantly reduced. However, the decrease of CD56 expression was not significant. CD25 expression seemed to be proportional to the LAK activity of the cells. This study demonstrated that cryopreserved lymphocytes, after 4 days of culture with rIL‐2, could be as active and could express the CD25 and CD56 cell surface markers in the same manner as fresh LAK cells.

Từ khóa


Tài liệu tham khảo

10.1084/jem.155.6.1823

10.1016/0022-1759(88)90238-4

Sondel PM, 1986, Destruction of autologous human lymphocytes by interleukin 2‐activated cytotoxic cells, Jr Immunol, 137, 502, 10.4049/jimmunol.137.2.502

10.1084/jem.164.3.814

Weil‐Hillman G., 1989, Lymphokine‐activated killer activity induced by in vivo interleukin 2 therapy: Predominant role for lymphocytes with increased expression of CD2 and Leu 19 antigens but negative expression of CD 16 antigens, Cancer Res, 49, 3680

Zhou M., 1990, Assay of lymphokine‐activated killer activity generated from bone marrow cells of children with acute lymphoblastic leukemia, Blood, 75, 160, 10.1182/blood.V75.1.160.160

Keever CA, 1987, Interleukin 2‐activated killer cells in patients following transplant of soybean lectin‐separated and E rosette‐depleted bone marrow, Blood, 70, 1893, 10.1182/blood.V70.6.1893.1893

Rees RC, 1990, The biology and clinical applications of interleukin 2, Immunol Today, 2, 36, 10.1016/0167-5699(90)90012-X

Lotze MT, 1985, In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL2, J Immunol, 135, 2865, 10.4049/jimmunol.135.4.2865

10.1007/BF00320242

10.1002/hep.1840100318

10.1016/0022-1759(86)90015-3

10.1007/BF00397919

Gottlieb DJ, 1989, Effect of recombinant interleukin 2 administration on cytotoxic function following high‐dose chemoradiotherapy for hematological malignancy, Blood, 74, 2335, 10.1182/blood.V74.7.2335.2335

Strong DM, 1975, Immunological responsiveness of frozen thawed human lymphocytes, Clin Exp Immunol, 21, 442

10.1016/0022-1759(80)90248-3

10.1046/j.1537-2995.1988.28689059025.x

10.1016/0022-1759(89)90092-6

10.1007/BF01665012

10.1002/stem.5530070204

10.1016/0008-8749(89)90298-0

10.1016/0022-1759(86)90454-0

Wood N., 1976, Niaid manual of tissue typing techniques, 203

10.1007/BF00915224

Adler A., 1989, Interleukin 2 induction of lymphokine‐activated killer activity in the peripheral blood and bone marrow of acute leukemia patients: II. Feasibility of LAK generation in children with active disease and in remission, Blood, 74, 1690, 10.1182/blood.V74.5.1690.1690

Thông tin
Thông tin xuất bản

Vox Sanguinis

Tập 61 Số 2

90-95

Thông tin tác giả